In a patient with chronic low blood urea nitrogen, new-onset hyperbilirubinemia, neurocognitive impairment, and infertility, which metabolic disorders are most likely?

Urea Cycle Disorders (UCDs) are the Most Likely Metabolic Disorders

In a patient presenting with chronic low blood urea nitrogen, new-onset hyperbilirubinemia, neurocognitive impairment, and infertility, urea cycle disorders—particularly ornithine transcarbamylase (OTC) deficiency—represent the most likely diagnosis. This constellation of findings directly points to impaired nitrogen metabolism with secondary hepatic and neurological consequences.

Diagnostic Reasoning

Low Blood Urea Nitrogen: The Key Diagnostic Clue

Chronic low BUN (<50 mg/L) is pathognomonic for impaired urea synthesis, which occurs in UCDs 1. The urea cycle is the primary mechanism for converting toxic ammonia into water-soluble urea for excretion. When any of the six enzymes (CPS1, OTC, ASS, ASL, ARG1, or NAGS) are deficient, ammonia accumulates while urea production drops 2.

OTC deficiency is the most common UCD (1 in 56,500 births) and follows X-linked inheritance, making it particularly relevant in male patients or female carriers with skewed X-inactivation 2. Other UCDs follow autosomal recessive patterns 1.

Hyperbilirubinemia: Hepatic Manifestation

The new-onset hyperbilirubinemia likely reflects:

• Secondary hepatic dysfunction from chronic hyperammonemia causing hepatocellular injury
• Crigler-Najjar syndrome should be considered in the differential, though this typically presents with isolated unconjugated hyperbilirubinemia from birth and lacks the low BUN and neurocognitive features 1

In UCDs, the liver maintains synthetic function initially but can develop progressive dysfunction from recurrent hyperammonemic crises 1.

Neurocognitive Impairment: The Devastating Consequence

Hyperammonemia causes irreversible neurological damage through multiple mechanisms 3, 4:

• Ammonia crosses the blood-brain barrier and is metabolized to glutamine by astrocytes
• This causes increased intracellular osmolality, cerebral edema, and inflammatory cytokine release
• NMDA receptor activation leads to excitotoxic cell death
• Chronic hyperammonemia impairs the glutamate-nitric oxide-cGMP pathway, affecting cognition and learning 4

Late-onset UCDs in adults present with 2, 3:

• Headache and lethargy
• Avoidance of high-protein foods
• Psychiatric symptoms (irritability, delusion, psychosis)
• Developmental delay and learning disabilities
• Seizures
• Attention deficit and autism spectrum features

Infertility: The Overlooked Complication

While not extensively detailed in the provided guidelines, infertility can occur in UCDs through:

• Chronic protein malnutrition from dietary restrictions
• Hormonal dysregulation from hepatic dysfunction
• Direct toxic effects of hyperammonemia on gonadal function

Diagnostic Workup

Immediate laboratory evaluation should include:

1. Plasma ammonia level (fasting, properly collected) - expect elevation >50 µmol/L 2
2. Plasma amino acids - look for:
   • Elevated glutamine (from ammonia detoxification)
   • Low citrulline (suggests proximal UCD: CPS1 or OTC deficiency)
   • Elevated citrulline (suggests ASS deficiency)
   • Elevated argininosuccinate (suggests ASL deficiency)
3. Urine orotic acid - markedly elevated in OTC deficiency, normal in CPS1 deficiency 5
4. Urine organic acids - to exclude organic acidemias (methylmalonic, propionic, isovaleric acidemia) which can cause secondary hyperammonemia 5
5. Genetic testing - definitive diagnosis requires identification of pathogenic variants in urea cycle enzyme genes 3

Avoid common pitfalls:

• Ammonia samples must be collected on ice and analyzed immediately; delayed processing causes falsely elevated results
• Hyperammonemia can be triggered by protein loading, catabolism, or certain medications (valproic acid) 1
• Normal ammonia during evaluation does NOT exclude UCD in late-onset forms 3

Alternative Diagnoses to Consider

Organic Acidemias

These can present with similar features but typically show 5:

• Metabolic acidosis with elevated anion gap
• Ketosis
• Characteristic organic acid patterns on urine analysis
• BUN may be low but not as consistently as in UCDs

Crigler-Najjar Type I

This presents with 1:

• Isolated unconjugated hyperbilirubinemia from birth
• Normal BUN and ammonia
• No neurocognitive impairment unless kernicterus develops
• Does not explain the low BUN or infertility

Hepatic Dysfunction from Other Causes

Chronic liver disease can cause low BUN from decreased synthetic capacity 6, but:

• Would show other signs of hepatic failure (coagulopathy, hypoalbuminemia)
• Hyperbilirubinemia would be predominantly conjugated
• Does not explain the specific pattern of neurocognitive impairment

Immediate Management Priorities

If UCD is confirmed, urgent intervention is critical to prevent further neurological damage 1:

1. Protein restriction - limit to 1.0-1.5 g/kg/day with essential amino acid supplementation
2. Ammonia scavengers 3:
   • Sodium benzoate (250-550 mg/kg/day)
   • Sodium phenylbutyrate (450-600 mg/kg/day)
3. Arginine or citrulline supplementation (100-250 mg/kg/day) - provides alternative pathway for nitrogen disposal
4. Hemodialysis if ammonia >200 µmol/L or neurological deterioration despite medical therapy 2
5. Liver transplantation evaluation - curative for proximal UCDs (CPS1, OTC, ASS) as these enzymes are exclusively hepatic 1, 7

The prognosis depends on the degree of existing neurological damage - liver transplantation stabilizes but does not reverse established cognitive deficits 1.